All news

Piramal expands ADC capacity predicting market growth

Piramal expands ADC capacity predicting market growth

By Gareth Macdonald

Piramal Healthcare has added commercial-scale antibody-drug-conjugate (ADC) manufacturing capacity at its UK plant predicting increasing demand for this specialist type of contracting.

Follow us

Webinars